HHS Secretary Robert F. Kennedy Jr. asked the FDA "to review the latest data on mifepristone ," but experts say concerns about the abortion pill's safety are misguided.

A recent appellate decision that allowed West Virginia to block access to the abortion-inducing drug mifepristone is fueling ...

Pro-life medical groups are urging Health and Human Services Secretary Robert Kennedy Jr. to reexamine the FDA’s broad ...

WEDNESDAY, July 16, 2025 (HealthDay News) — A federal appeals court has ruled that West Virginia can limit access to ...

AAPLOG Vice Chair Dr. Susan Bane discusses the potential health risks of abortion drugs like mifepristone on ‘Fox & Friends ...

A top official at the U.S. Food and Drug Administration (FDA) confirmed on Monday that the organization will conduct a review of the abortion drug mifepristone following several recent studies ...

Trump's DOJ has issued a new legal opinion barring federal funds from being used for transportation and other "ancillary ...

A new study has led to Health and Human Services Secretary Robert F. Kennedy, Jr. to order a “complete review” of the abortion pill, mifepristone, amid queries from Congress.. Sen. Josh Hawley (R-MO) ...

Food and Drug Administration Commissioner Marty Makary’s pledge to reexamine the safety of medication abortion isn’t just pointless — it’s dangerous. While the FDA has yet to announce when this review ...

The ruling reverses the judge’s own decision from two years ago that allowed Washington state and 17 other states to continue ...

Presented by Alliance for Pharmacy Compounding — The Food and Drug Administration commissioner has committed to reviewing the abortion drug mifepristone after previously stating he had no plans ...